tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market
4XC1
KalVista Pharmaceuticals
RESEARCH TOOLSreports

KalVista Pharmaceuticals (4XC1) Balance Sheet

0 Followers

KalVista Pharmaceuticals Balance Sheet

KalVista Pharmaceuticals's total assets for Q3 2026 were $335.38M, a decrease of -1.34% from the previous quarter. DE:4XC1 total liabilities were $338.09M for the fiscal quarter, a 4.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 25Apr 24Apr 23Apr 22Apr 21
Total Assets
$ 250.77M$ 235.40M$ 183.20M$ 203.88M$ 272.01M
Total Liabilities
$ 155.38M$ 28.82M$ 22.18M$ 18.79M$ 14.82M
Total Equity Gross Minority
$ 95.39M$ 206.58M$ 161.03M$ 185.09M$ 257.19M
Other Metrics
Currency in USD

KalVista Pharmaceuticals Debt to Assets